Ortin Laboratories Ltd
ORTINLABOrtin Laboratories Ltd
ORTINLABPrice Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
-3.85 | 1.44 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
-220.89 | 7.35 | 0.67% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Ortin Laboratories Limited is engaged in the business of manufacturing and trading of pharmaceuticals, drugs and intermediates.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 60.63 | 63.52 | 62.20 | 80.16 | 167.89 | 197.58 | 8.22 | 8.42 | 6.06 | 3.47 | ||||||||||
Raw Materials | 41.85 | 45.08 | 38.48 | 56.30 | 141.54 | 165.15 | 4.08 | 4.61 | 3.89 | 6.81 | ||||||||||
Power & Fuel Cost | 4.55 | 4.68 | 4.75 | 4.10 | 5.67 | 5.39 | 0.11 | 0.22 | 0.24 | |||||||||||
Employee Cost | 1.74 | 2.13 | 2.59 | 2.78 | 3.68 | 4.72 | 0.85 | 0.74 | 0.68 | |||||||||||
Selling & Administrative Expenses | 1.88 | 3.30 | 2.53 | 2.23 | 3.42 | 4.71 | 1.06 | 1.42 | 0.72 | |||||||||||
Operating & Other expenses | 4.12 | 1.87 | 8.08 | 8.91 | 6.77 | 11.73 | 0.82 | 0.87 | 0.00 | |||||||||||
EBITDA | 6.49 | 6.46 | 5.77 | 5.84 | 6.81 | 5.88 | 1.30 | 0.56 | 0.53 | -3.34 | ||||||||||
Depreciation/Amortization | 1.64 | 1.65 | 1.70 | 1.69 | 1.75 | 1.96 | 0.29 | 0.29 | 0.25 | 0.21 | ||||||||||
PBIT | 4.85 | 4.81 | 4.07 | 4.15 | 5.06 | 3.92 | 1.01 | 0.27 | 0.28 | -3.55 | ||||||||||
Interest & Other Items | 3.52 | 3.42 | 2.94 | 3.49 | 3.22 | 3.21 | 0.87 | 0.81 | 0.40 | 0.52 | ||||||||||
PBT | 1.33 | 1.39 | 1.13 | 0.66 | 1.84 | 0.71 | 0.14 | -0.54 | -0.12 | -4.07 | ||||||||||
Taxes & Other Items | 0.43 | 0.57 | 0.63 | 0.00 | 0.56 | 1.29 | -0.81 | -0.13 | -0.02 | -0.01 | ||||||||||
Net Income | 0.90 | 0.82 | 0.50 | 0.66 | 1.28 | -0.58 | 0.95 | -0.41 | -0.10 | -4.06 | ||||||||||
EPS | 0.53 | 0.48 | 0.30 | 0.39 | 0.76 | -0.34 | 0.76 | -0.50 | -0.12 | -4.99 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Ortin Laboratories Ltd | -156.12 | 1.44 | — |
Sun Pharmaceutical Industries Ltd | 43.12 | 6.16 | 0.76% |
Cipla Ltd | 38.78 | 4.58 | 0.63% |
Dr Reddy's Laboratories Ltd | 21.96 | 4.25 | 0.67% |
Price Comparison
Compare ORTINLAB with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 1.45%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
ORTINLAB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 24, 2013
Dividend/Share
₹0.25
Ex DateEx Date
Sep 24, 2013
Cash Dividend
Ex DateEx DateSep 24, 2012
Dividend/Share
₹0.50
Ex DateEx Date
Sep 24, 2012
Cash Dividend
Ex DateEx DateOct 13, 2011
Dividend/Share
₹0.50
Ex DateEx Date
Oct 13, 2011
Cash Dividend
Ex DateEx DateSep 23, 2010
Dividend/Share
₹0.80
Ex DateEx Date
Sep 23, 2010
News & Opinions
Ortin Laboratories reports standalone net profit of Rs 0.46 crore in the December 2022 quarter
1 year ago•Business Standard
Ortin Laboratories Ltd leads gainers in ‘B’ group
1 year ago•Business Standard
Ansal Housing Ltd leads gainers in ‘B’ group
1 year ago•Business Standard
Bhartiya International Ltd leads gainers in ‘B’ group
2 years ago•Business Standard
Pearl Polymers Ltd leads losers in ‘B’ group
2 years ago•Business Standard
K.P. Energy Ltd leads gainers in ‘B’ group
2 years ago•Business Standard
Ortin Laboratories standalone net profit declines 47.06% in the June 2021 quarter
2 years ago•Business Standard
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of -40.34%, vs industry avg of 8.36%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.04% to 0%